LEADS (Longitudinal Early-Onset Alzheimer’s Disease)

The Apostolova lab is affiliated with the Indiana Alzheimer Disease Center, the Center for Neuroimaging, as well as other departments and school centers. Alzheimer's is something that affects over three million people in the United States per year. Longitudinal Early-Onset AD Study will recruit, characterize, and follow 400 patients with definite Early- Onset Alzheimer’s Disease (EOAD) and 100 age-matched control subjects across 19 US clinical sites. Data is collected over a period of 24 months. It is split into baseline/screening, Month 12, and Month 24. Data is collected through these time spans to ensure there is enough of it. LEADS is supported by researchers all across the United States to research the progression of Early-Onset Alzheimer’s Disease by using imaging, cognitive testing, and biomarker data. Through this study they will be able to fill the gap in early-onset Alzheimer’s disease research.

Supervisor: Beenish Qureshi 
Department: Neurology